Sens. Portman, Cornyn, et al letter

Morning Consult - PhRMA National Poll - 5.1.15

PhRMA ITC Testimony - April 23, 2015

Clinical Trials Awareness Week Toolkit

PhRMA Statement on First FDA Approval of A Biosimilar Product

PhRMA supports a science-based, transparent implementation of the BPCIA biosimilars pathway.

2005 - 2015: A Decade of Innovation In Rare Diseases

Researching Hepatitis C Medicines: Setbacks and Stepping Stones

Researching Alzheimer’s Medicines: Setbacks and Stepping Stones

The Biopharmaceutical Pipeline: Evolving Science, Hope for Patients

Innovation in the Biopharmaceutical Pipeline: A Multidimensional View

A new study by the Analysis Group details how the U.S. biopharmaceutical industry leads the world in development of new medicines, with over 300 new prescription medicines approved by the U.S. Food and Drug Administration (FDA) over the past decade.


Subscribe to RSS - Innovation